Vaxcyte, Inc.
PCVX
$59.51
-$0.85-1.41%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -94.39% | -85.73% | -65.25% | -29.46% | -10.12% |
| Total Depreciation and Amortization | 39.91% | 46.58% | 56.89% | 41.67% | 59.53% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 152.36% | 71.36% | 78.04% | 114.61% | 107.61% |
| Change in Net Operating Assets | -7.08% | 241.13% | 93.71% | 195.96% | 213.92% |
| Cash from Operations | -91.76% | -67.46% | -44.84% | -15.34% | 1.57% |
| Capital Expenditure | 61.92% | 66.37% | 52.19% | 46.25% | 9.39% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 116.30% | 109.68% | 126.20% | 88.12% | -186.64% |
| Cash from Investing | 111.83% | 105.63% | 121.81% | 83.93% | -143.37% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -59.58% | -62.50% | -99.47% | -99.37% | 56.05% |
| Repurchase of Common Stock | 0.54% | 7.86% | 23.10% | 35.20% | -112.06% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -60.21% | -63.04% | -99.92% | -99.82% | 55.45% |
| Foreign Exchange rate Adjustments | 153.24% | 113.51% | 472.54% | 141.98% | -13.90% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 41.71% | 67.53% | -2,184.11% | -252.19% | -1,645.20% |